Skip to content

Clinical trials

Phase 3 Hypertension trials in Peru

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension Phase: Phase 3 Country / region: Peru Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20041
20051
20062
20071
20082
20091
20171
20181
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Active, not recruiting1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Takeda4
AstraZeneca2
Bayer1
Boehringer Ingelheim1
CSL Behring1
Novartis1
Novartis Pharmaceuticals1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1
Universidad Peruana Cayetano Heredia1
University of British Columbia1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension14
Cardiovascular Diseases3
Diabetes Mellitus2
Hyperlipidemias2
Renal Insufficiency, Chronic2
Stroke2
Acute Coronary Syndrome1
Atherosclerosis1
Atrial Fibrillation1
Chronic Disease1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.